Cambridge, UK – Eagle Genomics (“Eagle”) is pleased to announce it has raised additional financing of £3 million (USD $4 million) with continued participation from existing investors Environmental Technologies Fund, abrdn plc, and a consortium of investors headed by Granpool Innovative Investments, to further deploy its pioneering software platform that enables corporate customers to explore and monetize on microbiome-related […]
Espoo — Euformatics, a Finnish bioinformatics company that develops world-leading NGS interpretation and quality control tools, announced that it has signed a new commercial partnership with ELTA 90. As part of the collaboration, ELTA 90 and Euformatics plan to locally market the complex clinical diagnostic and genomic testing tools of Euformatics, to benefit the medical […]
> Dante to utilize Amazon Bedrock to build state-of-the-art large language model (LLM) with broad genomic and clinical applications – > Amazon Bedrock will leverage Dante’s expertise with clinical interpretation and massive whole genome database – > Groundbreaking collaboration pioneering the use case for LLMs in personalized medicine, enabling extraction of phenotypes of interest to […]
Global pharmaceutical company implements Genedata Selector to automate the analysis of NGS-driven assays for adventitious agent detection during cell therapy development Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that the Astellas Institute for Regenerative Medicine (AIRM), a subsidiary of Astellas Pharma Inc. and a global pharmaceutical […]
The SOPHiA DDM™ Platform will help Laboratorio Curie advance its research into BRCA gene mutations BOSTON and ROLLE, Switzerland — Sophia Genetics (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, has expanded its relationship with Laboratorio Curie, a leading laboratory located in the capital city of Paraguay. Laboratorio Curie is now live on the SOPHiA DDM™ Platform […]
Cambridge – Congenica, a leading digital health company specialising in the provision of software and solutions for genomic data analysis and interpretation, and myTomorrows, a global platform facilitating access to pre-approval treatments and clinical trials, have partnered to expedite access to precision oncology for cancer patients worldwide. The partnership between Congenica and myTomorrows will open […]
Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors MOUNTAIN VIEW, Calif., — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief […]
API gives easier access to QIAGEN Biomedical Knowledge Base, used by over 40,000 researchers Structured content from over 20 years of curation has been cited in over 57,000 scientific papers Enables large and small pharma and biotech companies to access vital data for drug discovery and other insights Venlo, the Netherlands, and Redwood City, California […]
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Dr. Ben M. W. Illigens, an experienced clinician and neuroscientist, as the company’s Chief Medical Officer. BCP’s CMO will be overseeing the operational work underpinning the company’s rapidly expanding global patient data sourcing and data network development, which provides […]
With the help of the SOPHiA DDM™ Platform, IRST has introduced a new diagnostic kit that will support data-driven treatment planning for advanced ovarian cancer BOSTON, USA and ROLLE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, is helping excel the use of precision medicine to treat advanced ovarian […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
